Statistics for Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
Total visits
| views | |
|---|---|
| Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma. | 2 |
Total visits per month
| views | |
|---|---|
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
File Visits
| views | |
|---|---|
| Articulo.pdf | 36 |
Top country views
| views | |
|---|---|
| Brazil | 1 |
| Chile | 1 |
Top city views
| views | |
|---|---|
| Santiago | 1 |
| Sao Joao do Rio do Peixe | 1 |